KELLY HENDERSON: Open Payments
NPI 1598374233 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 28 payments from 11 companies in 2025. Trend: 2023 $244 · 2024 $380 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $303 |
| Amgen Inc. | 1 | $79 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, QULIPTA, OTEZLA, VOQUEZNA, Cologuard Collection Kit, Ozempic, AIRSUPRA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
